GlassScriptPhysician profile
Joycelyn L Howard
NPI 1265812010
$496.75
in general payments reported to CMS, 2019-2025
11 companies · $458 in 2025
The $458 reported for 2025 was more than what 75% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $38.42 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.76 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $147.46 | 2025 | Keytruda, Welireg, Reblozyl |
| Seagen INC. | $99.99 | 2025 | |
| Daiichi Sankyo INC. | $59.13 | 2024-2025 | Enhertu, Datroway |
| Regeneron Healthcare Solutions, INC. | $55.06 | 2024-2025 | Libtayo, Dupixent |
| Emd Serono, INC. | $26.83 | 2025 | |
| Janssen Biotech, INC. | $23.63 | 2025 | Tecvayli |
| Deciphera Pharmaceuticals INC. | $19.42 | 2025 | Qinlock |
| Takeda Pharmaceuticals U.S.A., INC. | $18.66 | 2025 | Iclusig |
| Pfizer INC. | $16.83 | 2025 | |
| Beone Medicines USA, INC. | $15.78 | 2025 | Brukinsa |
| Astrazeneca Pharmaceuticals LP | $13.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joycelyn Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.